The $370.8 billion in 2019 would account for 10 percent of overall health expenditures in the nation.
Fitch Solutions said Medicare is on course to become the leading payer for prescription drugs in the U.S. and forecasts out-of-pocket spending to become more common this year because of the removal of a penalty for not having insurance.
The report also estimates the U.S. pharma sales will reach $420 billion in 2023, accounting for 9.7 percent of overall health expenditures.
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer
